Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study

Abstract

There results suggest that intravitreal injection of bevacizumab seems to be associated with reduced neovascularisation without apparent ocular or systemic adverse effects, and is thus beneficial for treating severe ROP that is refractory to conventional laser therapy.